Codexis, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Codexis, Inc. on February 16, 2024, covering events occurring on February 13, 2024. The filing addresses corporate governance matters regarding the Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to a specific corporate event and does not contain financial statements.
Material Changes
On February 13, 2024, Jennifer Aaker, Ph.D., notified the Board of Directors of her intention not to stand for reelection at the 2024 Annual Meeting of Stockholders. Dr. Aaker will remain a director until the conclusion of the 2024 Annual Meeting. The Company stated that this decision is not the result of any disagreement with the Company regarding its operations, policies, or practices.
Guidance, Outlook, and Risks
The filing contains no management commentary on financial guidance, outlook, risks, contingencies, or unusual items.
Key Facts for Investor Verification
- Dr. Jennifer Aaker will not seek reelection to the Board at the 2024 Annual Meeting.
- Dr. Aaker's departure is voluntary and unrelated to any disagreement with the Company.
- Dr. Aaker will continue to serve as a director until the 2024 Annual Meeting.
- The filing does not disclose any financial performance data or changes in financial condition.